A risk model to predict the delivery of adjuvant chemotherapy following lung resection in patients with pathologically positive lymph nodes
To investigate factors associated with the ability to receive adjuvant chemotherapy in patients with pathological N1 and N2 stage after anatomic lung resections for non-small cell lung cancer (NSCLC). Multicenter retrospective analysis on 707 consecutive patients found pathologic N1 (pN1) or N2 (pN2) disease following anatomic lung resections for NSCLC (2014-2019). Multiple imputation logistic regression was used to identify factors associated with adjuvant chemotherapy and to develop a model to predict the probability of starting this treatment.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Miriam Patella, Alessandro Brunelli, Laura Adams, Stefano Cafarotti, Lorena Costardi, Paul De Leyn, Herbert Decaluw é, Kevin N. Franks, Marta Fuentes, Marcelo F. Jimenez, Sunanda Karri, Johnny Moons, Pierluigi Novellis, Enrico Ruffini, Giulia Veronesi, E Tags: THORACIC – Original Submission Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chemotherapy | Heart | Lung Cancer | Non-Small Cell Lung Cancer